Back to results

Cumming School of Medicine

Voltage gated calcium channels – molecular targets for trigeminal neuralgia

Abstract

dc:description.abstract

Trigeminal neuralgia (TN) is a rare debilitating disease which is characterised by excruciating facial pain and has a higher incidence in women. Recent studies demonstrated that some TN patients present mutations in genes that encode different voltage-gated calcium channels, a class of ion channel that are important players in pain pathways. Among them, mutations in the genes CACANA1A, CACNA1G, and CACNA1H, that encode CaV2.1, CaV3.1 and CaV3.2 channels, respectively, were investigated. First, we characterised the biophysical properties of these mutations using whole-cell patch-clamp recordings in tsA-201 cells. Second, we investigated the role of CaV3.2 channels in an animal model of trigeminal neuropathic pain. Finally, we explored the molecular mechanism of a selective T-type calcium channel blocker. Our data demonstrated a mix of loss- and gain-of-function in the CaV2.1 channel mutant P2455H, and a gain-of-function in a CaV3.1 channel variant (R706Q). For the CaV3.2 channel mutants, some presented a gain-of-function (G563R, P566T, P1605H), some a loss-of-function (E281K, H526Y, R1736C), and one exhibited no difference to wild type channels (D1779Y). These changes in channel function may affect pain pathways in the trigeminal system, thus potentially contributing to the pain phenotype. Considering that several studies demonstrated that CaV3.2 channels are dysregulated in models of chronic pain, we assessed the function of this channel in the constriction of the infraorbital nerve (CION) model. Both female and male CION mice developed facial thermal heat hyperalgesia. Treatment with the pan T-type blocker Z944 was able to produce an antihyperalgesic effect in CION mice, however its effect was absent in CaV3.2-/- mice. This suggests that Z944 targets CaV3.2 channels in the CION model. ELISA analysis revealed increased CaV3.2 channel expression in the spinal trigeminal subnucleus caudalis. Finally, the T-type channel blocker DX-416 was able to block CaV3.2 calcium channel current, however its effect is not altered by mutations in putative sites for A803467. Altogether, the present study demonstrates an important role of voltage-gated calcium channels in trigeminal pain.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy (PhD)
Discipline thesis:degree_discipline
Medicine – Neuroscience
Grantor dc:publisher.institution
Cumming School of Medicine
Year dc:date.issued
2022

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Gambeta de Andrade, Eder
Advisor dc:contributor.advisor
  • Zamponi, Gerald
Committee members dc:contributor.committeemember
  • Altier, Christophe
  • Turner, Ray
  • Ousman, Shalina
  • Hildebrand, Michael

Rights

dc:rights
Statement dc:rights
  • University of Calgary graduate students retain copyright ownership and moral rights for their thesis. You may use this material in any way that is permitted by the Copyright Act or through licensing that has been assigned to the document. For uses that are not allowable under copyright legislation or licensing, you are required to seek permission.

Identifiers

dc:identifier.*
OAI identifier oai:identifier
oai:ucalgary.scholaris.ca:1880/115604

Chain of custody

source
Harvested from
University of Calgary
Base URL
ucalgary.scholaris.ca/server/oai/request
Last updated
2026-07-24
Source record
OAI-PMH GetRecord
related terms
citation

Gambeta de Andrade, Eder. Voltage gated calcium channels – molecular targets for trigeminal neuralgia. Cumming School of Medicine, 2022. http://hdl.handle.net/1880/115604